Sio Gene Therapies Announces Fiscal Year 2021 Year-End Financial Results
Provided By Globe Newswire
Last update: Jun 14, 2022
NEW YORK and DURHAM, N.C., June 14, 2022 (GLOBE NEWSWIRE) -- Sio Gene Therapies Inc. (NASDAQ: SIOX) today provided financial results for its fiscal year ended March 31, 2022.
